Grifols SA
MAD:GRF

Watchlist Manager
Grifols SA Logo
Grifols SA
MAD:GRF
Watchlist
Price: 10.99 EUR 0.73% Market Closed
Market Cap: 7.5B EUR

Relative Value

The Relative Value of one GRF stock under the Base Case scenario is 35.74 EUR. Compared to the current market price of 10.99 EUR, Grifols SA is Undervalued by 69%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GRF Relative Value
Base Case
35.74 EUR
Undervaluation 69%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
87
Median 3Y
1
Median 5Y
1.1
Industry
7.9
Forward
1
vs History
84
vs Industry
4
Median 3Y
37
Median 5Y
29.5
Industry
23.7
Forward
14.1
vs History
71
vs Industry
14
Median 3Y
5.2
Median 5Y
18.2
Industry
22
vs History
vs Industry
Median 3Y
-11
Median 5Y
-6.6
Industry
24.3
vs History
46
vs Industry
58
Median 3Y
1.2
Median 5Y
1.4
Industry
3.3
vs History
69
vs Industry
67
Median 3Y
2.2
Median 5Y
2.3
Industry
8.2
Forward
2.1
vs History
71
vs Industry
56
Median 3Y
5.6
Median 5Y
6
Industry
10.2
vs History
87
vs Industry
12
Median 3Y
12.4
Median 5Y
14.9
Industry
6.1
Forward
8.6
vs History
90
vs Industry
10
Median 3Y
16.1
Median 5Y
18.2
Industry
6.5
Forward
11.4
vs History
69
vs Industry
11
Median 3Y
10.5
Median 5Y
25.8
Industry
7.9
vs History
53
vs Industry
6
Median 3Y
-65.4
Median 5Y
19.5
Industry
6.3
vs History
55
vs Industry
61
Median 3Y
0.8
Median 5Y
0.8
Industry
5.7

Multiples Across Competitors

GRF Competitors Multiples
Grifols SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Grifols SA
MAD:GRF
7.5B EUR 1 20 7.4 11.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 667 065.8 -160 014.6 -194 308.7 -192 091.4
US
Abbvie Inc
NYSE:ABBV
406.5B USD 6.8 173.1 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
179.1B USD 5 25.6 18.4 18.4
US
Gilead Sciences Inc
NASDAQ:GILD
154.9B USD 5.3 19.1 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.6B USD 10 32 23.5 24.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 092.5 -534 -581.4 -565.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 5.8 18.1 17.3 19.6
AU
CSL Ltd
ASX:CSL
83B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD 16.4 1 211.8 163.4 198.2
NL
argenx SE
XBRU:ARGX
44B EUR 14.4 33.8 58.2 59.8
P/E Multiple
Earnings Growth PEG
ES
Grifols SA
MAD:GRF
Average P/E: 172.5
20
74%
0.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 014.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.6
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 211.8
N/A N/A
NL
argenx SE
XBRU:ARGX
33.8
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ES
Grifols SA
MAD:GRF
Average EV/EBITDA: 36.7
7.4
12%
0.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 308.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.4
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
11%
1.6
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.4
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
ES
Grifols SA
MAD:GRF
Average EV/EBIT: 42.7
11.6
15%
0.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 091.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.4
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.2
N/A N/A
NL
argenx SE
XBRU:ARGX
59.8
N/A N/A